Improving the efficacy of antibody-based cancer therapies

  title={Improving the efficacy of antibody-based cancer therapies},
  author={Paul H Carter},
  journal={Nature Reviews Cancer},
A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases, including cancer. Although antibodies have yet to achieve the ultimate goal of curing cancer, many innovative approaches stand poised to improve the efficacy of antibody-based therapies. 
Highly Influential
This paper has highly influenced a number of papers. REVIEW HIGHLY INFLUENTIAL CITATIONS